Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04839328
What this trial is testing

A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Tianjin Hemay Pharmaceutical Co., Ltd 306
Testing effectiveness (Phase 2)Study completedNCT02070965
What this trial is testing

DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Primus Pharmaceuticals 75
Large-scale testing (Phase 3)Study completedNCT03611751
What this trial is testing

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 1,020
Large-scale testing (Phase 3)Study completedNCT00679731
What this trial is testing

Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie (prior sponsor, Abbott) 317
Large-scale testing (Phase 3)Study completedNCT03364309
What this trial is testing

Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 438
Post-approval studies (Phase 4)Not Yet RecruitingNCT07373847
What this trial is testing

Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia

Who this might be right for
Plaque Psoriasis
Xiangya Hospital of Central South University 40
Not applicableStudy completedNCT00749398
What this trial is testing

Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 133
Post-approval studies (Phase 4)Study completedNCT01511315
What this trial is testing

The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment

Who this might be right for
Psoriasis
University of California, San Francisco 36
Post-approval studies (Phase 4)Study completedNCT03573323
What this trial is testing

Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 1,027
Testing effectiveness (Phase 2)Study completedNCT05357755
What this trial is testing

JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 90
Testing effectiveness (Phase 2)Study completedNCT03635099
What this trial is testing

This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is

Who this might be right for
Psoriasis
Boehringer Ingelheim 274
Early research (Phase 1)Study completedNCT06182384
What this trial is testing

A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices

Who this might be right for
Moderate-to-Severe Plaque Psoriasis
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 46
Post-approval studies (Phase 4)Study completedNCT00791765
What this trial is testing

Moderate to Severe Plaque Psoriasis With Scalp Involvement

Who this might be right for
Psoriasis
Amgen 124
Testing effectiveness (Phase 2)Study completedNCT02295865
What this trial is testing

Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 62
Not applicableStudy completedNCT03026153
What this trial is testing

Biologics Anchoring Study

Who this might be right for
Moderate-to-severe Psoriasis
Wake Forest University Health Sciences 100
Large-scale testing (Phase 3)Study completedNCT02207231
What this trial is testing

Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 837
Post-approval studies (Phase 4)Ended earlyNCT02829424
What this trial is testing

Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Assistance Publique Hopitaux De Marseille 78
Not applicableEnrolling By InvitationNCT06999941
What this trial is testing

A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features

Who this might be right for
PsoriasisEczemaJAK Inhibitor
Xi Tan 50
Not applicableStudy completedNCT01812954
What this trial is testing

Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis

Who this might be right for
Psoriasis
Jochen Schmitt. 1
Testing effectiveness (Phase 2)Study completedNCT02203851
What this trial is testing

Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 110
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation